TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35904750

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (acetyl-salicylic acid plus a P2Y12 inhibitor)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Antiplatelet monotherapy (a P2Y12 inhibitor) plus low dose anticoagulant (rivaroxaban, 15mg oral dose)
Number of subjects: 60
Study: 32927668

Group type: EXPERIMENTAL
Intervention: 10 g per day of cocoa-rich chocolate (99%) for 6 months
Number of subjects: 140
Study: 36217289

Group type: EXPERIMENTAL
Intervention: Rabbit Anti-Thymocyte Globulin (rATG) 5 mg/kg from days -5 to -2
Number of subjects: 85

Group type: COMPARATOR
Intervention: Non-ATG
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Rabbit Anti-Thymocyte Globulin (rATG)
Number of subjects: 85
Study: 33715931

Group type: EXPERIMENTAL
Intervention: Foot reflexology for an average of 20 min before heel lance
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 60
Study: 35469478

Group type: EXPERIMENTAL
Intervention: 50 mg diclofenac sodium
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 33333285

Group type: EXPERIMENTAL
Intervention: Prednisone (10 mg, qd, from the first day postoperatively, for 2 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (routine analgesic regimens including injection of cocktail mixture intraoperatively, oral celecoxib and tramadol postoperatively)
Number of subjects: 49
Study: 33977506

Group type: EXPERIMENTAL
Intervention: Losartan 12.5 mg orally every 12 h for 10 days plus standard of care (SOC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 31
Study: 32114516

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) and optimal medical therapy (OMT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT)
Number of subjects: 104
Study: 35959805

Group type: EXPERIMENTAL
Intervention: UCB0599
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 33978130

Group type: EXPERIMENTAL
Intervention: New Moves program (participation in 1 to 9 sessions)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: New Moves program (participation in 10 to 17 sessions)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: New Moves program
Number of subjects: 270
Study: 33295977

Group type: EXPERIMENTAL
Intervention: Burnout (measured using subscales of the Stanford Professional Fulfillment Index, Maslach Burnout Inventory‐Human Services Survey for Medical Personnel, and Mini‐Z burnout survey)
Number of subjects: 1354

Group type: EXPERIMENTAL
Intervention: Depression (measured using the Patient‐Reported Outcomes Measurement Information System depression Short Form)
Number of subjects: 1354

Group type: EXPERIMENTAL
Intervention: Burnout
Number of subjects: 1354

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 1354
Study: 36218286

Group type: EXPERIMENTAL
Intervention: Smart Beginnings (SB) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34304069

Group type: EXPERIMENTAL
Intervention: Greater Occipital Nerve (GON) block with 1% lidocaine
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Supra Orbital Nerve (SON) block with 1% lidocaine
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Combined GON and SON block with 1% lidocaine
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo with 0.9% NaCl
Number of subjects: 128
Study: 36398542

Group type: EXPERIMENTAL
Intervention: Vitamin D3 800 IU/d (subgroup A)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Individualized vitamin D3 supplementation (subgroup B)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Sufficiency group
Number of subjects: 161

Group type: COMPARATOR
Intervention: Deficiency group
Number of subjects: 161
Study: 33268434

Group type: EXPERIMENTAL
Intervention: Endoscopic polypectomy performed in clinic (EPIC)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Endoscopic sinus surgery (ESS)
Number of subjects: 140
Study: 34283529

Group type: EXPERIMENTAL
Intervention: Neurouridin dietary supplement
Number of subjects: 3179

Group type: COMPARATOR
Intervention: Control group (no neurouridin)
Number of subjects: 3179
Study: 32105112

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Seeking Safety (SS)
Number of subjects: 107
Study: 34981420

Group type: EXPERIMENTAL
Intervention: IV norepinephrine + oral midodrine 10 mg thrice a day
Number of subjects: 60

Group type: COMPARATOR
Intervention: IV norepinephrine
Number of subjects: 60
Study: 34106626

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl cellulose soluble hemostatic gauze
Number of subjects: 282

Group type: COMPARATOR
Intervention: Sterile gauze
Number of subjects: 282
Study: 35316858

Group type: EXPERIMENTAL
Intervention: Music therapy along with conscious sedation (Group A)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Conscious sedation alone (Group B)
Number of subjects: 109
Study: 32098012

Group type: EXPERIMENTAL
Intervention: Sevoflurane-based anesthesia (volatile anesthetic)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Propofol-based anesthesia (intravenous anesthetic)
Number of subjects: 20
Study: 33566466

Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 568

Group type: COMPARATOR
Intervention: Control group (no osmotherapy)
Number of subjects: 568
Study: 32512710

Group type: EXPERIMENTAL
Intervention: 200 mg of porcine placenta extract once daily for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34191034

Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME) protocol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Alternating Rapid Maxillary Expansion and Constriction (Alt‐RAMEC) protocol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison of RME and Alt‐RAMEC groups
Number of subjects: 36

Group type: COMPARATOR
Intervention: Age and sex relationship with STT
Number of subjects: 36
Study: 34863192

Group type: EXPERIMENTAL
Intervention: Incentive (30% incentive for fruits and vegetables purchased with study benefits)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Restriction (not allowed to buy sugar-sweetened beverages, sweet baked goods, or candy using study benefits)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Incentive plus restriction
Number of subjects: 249

Group type: COMPARATOR
Intervention: Control (no incentive or restriction)
Number of subjects: 249
Study: 32278421

Group type: EXPERIMENTAL
Intervention: Near infrared spectroscopy using lyophilized wine samples
Number of subjects: 0
Study: 616172503

Group type: EXPERIMENTAL
Intervention: NT-proBNP guided therapy (group 1)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard heart failure therapy (group 2)
Number of subjects: 105
Study: 34726348

Group type: EXPERIMENTAL
Intervention: Plasma exchange (PE) with albumin replacement
Number of subjects: 347

Group type: COMPARATOR
Intervention: Placebo (sham-PE)
Number of subjects: 347
Study: 33257214

Group type: EXPERIMENTAL
Intervention: Complete revascularization (ComR)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Selective stress echocardiography-guided revascularization (SelR)
Number of subjects: 306
Study: 35861908

Group type: EXPERIMENTAL
Intervention: Class IIa medical device containing lactic acid, azelaic acid/polyglyceryl‐3 copolymer, azelamidopropyl dimethyl amine, and bifida ferment lysate, used twice daily for 2 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33840781

Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum‐aaes (CCH) 0.84 mg
Number of subjects: 843

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 843
Study: 35343453

Group type: EXPERIMENTAL
Intervention: Oral hygiene instructions (OHI)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: One-stage full-mouth scaling and root planning (SRP) combining OHI
Number of subjects: 64
Study: 33346847

Group type: EXPERIMENTAL
Intervention: Remote monitoring (n=147) including wearable activity monitor, messaging about postoperative goals, pain score tracking, and connection to clinicians.
Number of subjects: 242

Group type: COMPARATOR
Intervention: Usual care (n=153)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Remote monitoring with gamification and social support
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Remote monitoring (n=147)
Number of subjects: 242
Study: 34265576

Group type: EXPERIMENTAL
Intervention: Plantago major seed (3600 mg/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Roasted wheat flour (control)
Number of subjects: 61
Study: 34478564

Group type: EXPERIMENTAL
Intervention: Bipolar energy (Group 1)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Hemostatic sealants (Group 2)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Suture (Group 3)
Number of subjects: 84

Group type: COMPARATOR
Intervention: All groups (Bipolar energy, Hemostatic sealants, Suture)
Number of subjects: 84
Study: 33499861

Group type: EXPERIMENTAL
Intervention: Consumption of flesh foods
Number of subjects: 1517

Group type: EXPERIMENTAL
Intervention: Consumption of eggs
Number of subjects: 1517

Group type: EXPERIMENTAL
Intervention: Meal frequency of three times or more per day
Number of subjects: 1517

Group type: EXPERIMENTAL
Intervention: Greater than mild pubertal development in males
Number of subjects: 1517

Group type: COMPARATOR
Intervention: Female adolescents compared to males
Number of subjects: 1517

Group type: COMPARATOR
Intervention: Mothers with completed high school education compared to <3 years of formal education
Number of subjects: 1517
Study: 33334195

Group type: EXPERIMENTAL
Intervention: Xylitol tablets with red propolis (XPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xylitol tablets without red propolis (XT)
Number of subjects: 0
Study: 34233059

Group type: EXPERIMENTAL
Intervention: Indirect questioning technique
Number of subjects: 1366

Group type: COMPARATOR
Intervention: Direct questioning technique
Number of subjects: 1366
Study: 32102629

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35584324

Group type: EXPERIMENTAL
Intervention: HP35ca (bleached using 35% hydrogen peroxide with Ca)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HP35wca (bleached using 35% hydrogen peroxide without Ca)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (without bleaching)
Number of subjects: 60
Study: 33596885

Group type: EXPERIMENTAL
Intervention: Daytime sleepiness (Epworth Sleepiness Scale - ESS)
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: Lower ESS scores
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 1350
Study: 35362336

Group type: EXPERIMENTAL
Intervention: Probiotic treatment for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 32689628

Group type: EXPERIMENTAL
Intervention: GEAR
Number of subjects: 19

Group type: COMPARATOR
Intervention: Treadmill
Number of subjects: 19
Study: 33772845

Group type: EXPERIMENTAL
Intervention: Pramlintide infusion
Number of subjects: 36

Group type: COMPARATOR
Intervention: CGRP infusion
Number of subjects: 36
Study: 36479786

Group type: EXPERIMENTAL
Intervention: Early glargine group (subcutaneous insulin glargine 0.3 units/kg within the first 3 hours of DKA diagnosis, in addition to standard IV insulin infusion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standard IV insulin treatment only)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Early glargine group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 34735099

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 113

Group type: COMPARATOR
Intervention: Quetiapine extended release
Number of subjects: 113
Study: 32930090

Group type: EXPERIMENTAL
Intervention: Switching to an equivalent dose of quetiapine, aripiprazole, or olanzapine with brief psychoeducation and support.
Number of subjects: 98

Group type: COMPARATOR
Intervention: Enhanced standard care alone.
Number of subjects: 98
Study: 33533074

Group type: EXPERIMENTAL
Intervention: Melasolv™ applied twice a day for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo applied twice a day for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melasolv™
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32697485

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure guided by electrical impedance tomography (PEEPEIT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory transpulmonary pressure (PEEPPL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PEEPEIT
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PEEPPL
Number of subjects: 20
Study: 35103605

Group type: EXPERIMENTAL
Intervention: MyCourse (digital alcohol moderation intervention)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control (noninteractive digital information brochure)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: MyCourse
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control
Number of subjects: 103
Study: 34787294

Group type: EXPERIMENTAL
Intervention: Autogenic drainage (AD) plus routine chest physiotherapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine chest physiotherapy only
Number of subjects: 48
Study: 34699618

Group type: EXPERIMENTAL
Intervention: Nitazoxanide 1,500 mg orally twice-daily with food for 7 days
Number of subjects: 14
Study: 32493500

Group type: EXPERIMENTAL
Intervention: CAREDYNE Shield
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nanoseal
Number of subjects: 40
Study: 33771722

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 80 μg via Breezhaler® (low-dose ICS)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 320 μg via Breezhaler® (high-dose ICS)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Mometasone furoate via Breezhaler® (50-400 μg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Mometasone furoate via Twisthaler® (200 μg and 800 μg)
Number of subjects: 96
Study: 32429874

Group type: EXPERIMENTAL
Intervention: Less invasive surfactant administration via nasal route (LISA-n)
Number of subjects: 20
Study: 36253574

Group type: EXPERIMENTAL
Intervention: Adjunctive virtual classroom training (VCT) with the FRS curriculum
Number of subjects: 11

Group type: COMPARATOR
Intervention: Fundamentals of Robotic Surgery (FRS) curriculum only
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Adjunctive virtual classroom training (VCT) after initial training with FRS curriculum
Number of subjects: 11

Group type: COMPARATOR
Intervention: Fundamentals of Robotic Surgery (FRS) curriculum only (after receiving VCT)
Number of subjects: 11
Study: 36378836

Group type: EXPERIMENTAL
Intervention: Perineal electrical stimulation (ES), 3 days a week, 20 min a day, for 8 weeks (total of 24 sessions)
Number of subjects: 58

Group type: COMPARATOR
Intervention: No treatment (Control Group)
Number of subjects: 58
Study: 34237457

Group type: EXPERIMENTAL
Intervention: Recruitment and retention strategies
Number of subjects: 157
Study: 32650155

Group type: EXPERIMENTAL
Intervention: Land-based exercise training (LET)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Water-based exercise training (WET)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 53
Study: 36235546

Group type: EXPERIMENTAL
Intervention: Enhanced parenteral nutrition (higher glucose infusion rate and intralipids)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard parenteral nutrition
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Enhanced parenteral nutrition
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Higher enteral energy and protein intake (regardless of randomization group)
Number of subjects: 90
Study: 34090212

Group type: EXPERIMENTAL
Intervention: Individualized nutritional support to reach specific protein and energy goals
Number of subjects: 881

Group type: COMPARATOR
Intervention: Routine hospital food
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Individualized nutritional support
Number of subjects: 881
Study: 32801649

Group type: EXPERIMENTAL
Intervention: Test formulation of amitriptyline hydrochloride (25 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation of amitriptyline hydrochloride (25 mg)
Number of subjects: 24
Study: 36330537

Group type: EXPERIMENTAL
Intervention: Postpartum IUD (PPIUD) intervention
Number of subjects: 19431
Study: 36053364

Group type: EXPERIMENTAL
Intervention: 0.3 g kg-1 body mass NaHCO3 in chilled orange squash
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.3 g kg-1 body mass NaHCO3 in capsules
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (0.03 g kg-1 body mass sodium chloride)
Number of subjects: 28
Study: 33468147

Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine (AL)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DP)
Number of subjects: 720
Study: 35654932

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus consumption
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 32835786

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 36011834

Group type: EXPERIMENTAL
Intervention: Martial Arts Sensory Teaching Group (MAST)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Martial Arts Traditional Teaching Group (MATT)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Free Activity Group (FA)
Number of subjects: 87
Study: 32143063

Group type: EXPERIMENTAL
Intervention: Visual-manual SRTT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-choice task
Number of subjects: 0
Study: 36160279

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 33830626

Group type: EXPERIMENTAL
Intervention: Insulin degludec 100 units/mL (degludec)
Number of subjects: 8355

Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL (glargine U100)
Number of subjects: 8355
Study: 33825140

Group type: EXPERIMENTAL
Intervention: Vitamin-K1 [10 mg/day]
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Colchicine [0.5 mg/day]
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 34916643

Group type: EXPERIMENTAL
Intervention: Four-implant overdentures in the maxilla
Number of subjects: 24
Study: 33202169

Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg, 2 tablets three times a day for 14 days)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 32200486

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus metformin
Number of subjects: 126

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: CTC count
Number of subjects: 126
Study: 33586367

Group type: EXPERIMENTAL
Intervention: Inosine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33046584

Group type: EXPERIMENTAL
Intervention: Web-based tailored messaging intervention (VAYB)
Number of subjects: 824

Group type: COMPARATOR
Intervention: Untailored version of the intervention (UT)
Number of subjects: 824

Group type: COMPARATOR
Intervention: Usual care intervention (UC)
Number of subjects: 824

Group type: COMPARATOR
Intervention: Comparison of VAYB to UC
Number of subjects: 824

Group type: COMPARATOR
Intervention: Comparison of VAYB to UT
Number of subjects: 824

Group type: COMPARATOR
Intervention: Comparison of UT to UC
Number of subjects: 824
Study: 35723054

Group type: EXPERIMENTAL
Intervention: Walking Football (WF) program during Ramadan fasting (RF)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (participated in Ramadan fasting)
Number of subjects: 31
Study: 34167566

Group type: EXPERIMENTAL
Intervention: Mobile blood pressure management application
Number of subjects: 120
Study: 33376177

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered physical activity programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study: 35092760

Group type: EXPERIMENTAL
Intervention: Upper limb RIPC
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Lower limb RIPC
Number of subjects: 345

Group type: COMPARATOR
Intervention: Upper limb control
Number of subjects: 345

Group type: COMPARATOR
Intervention: Lower limb control
Number of subjects: 345
Study: 34315695

Group type: EXPERIMENTAL
Intervention: Probiotic treatment (2 g sachet daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no probiotic supplements)
Number of subjects: 80
Study: 36402160

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of foslevodopa-foscarbidopa plus oral placebo capsules
Number of subjects: 141
Study: 32468645

Group type: EXPERIMENTAL
Intervention: Talazoparib
Number of subjects: 0
Study: 35560315

Group type: EXPERIMENTAL
Intervention: Fortified BEP supplements and IFA
Number of subjects: 1897

Group type: COMPARATOR
Intervention: IFA
Number of subjects: 1897
Study: 33792019

Group type: EXPERIMENTAL
Intervention: Motivational interventions and mobile social network support for three months
Number of subjects: 121

Group type: COMPARATOR
Intervention: Regular care and a smoking cessation booklet
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study: 34938352

Group type: EXPERIMENTAL
Intervention: Nanosilver Burn Dressing (NSBD)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Sulfadiazine Silver Cream (SSC)
Number of subjects: 106
Study: 32869324

Group type: EXPERIMENTAL
Intervention: Hospitalization due to bleeding-related reasons
Number of subjects: 22429

Group type: EXPERIMENTAL
Intervention: Switching from warfarin to a direct oral anticoagulant after hospitalization
Number of subjects: 22429

Group type: EXPERIMENTAL
Intervention: Hospitalization (general)
Number of subjects: 22429